• Invo Fertility received a Nasdaq noncompliance notice tied to late filing of its annual report on Form 10-K for fiscal year 2025.
• Delay reflects extended review of complex accounting matters, including tax provision, warrant accounting, variable interest entity accounting.
• Nasdaq notice does not immediately affect listing, with shares continuing to trade under symbol IVF.
• Company has 60 days from April 23, 2026 to submit a compliance plan, with Nasdaq able to grant up to 180 days from April 15, 2026 to regain compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-019593), on April 29, 2026, and is solely responsible for the information contained therein.